Obesity, lipids, inflammation, and healthy aging.

Authors

Rishi Rikhi, Michael D Shapiro

Published in

Progress in cardiovascular diseases. Aug 20, 2026. Epub Aug 20, 2026.

Abstract

Cardiovascular disease (CVD) is the leading cause of death and disability globally. Thus, prevention efforts aimed at reducing CVD events allow for greater functional independence and wellbeing over the course of life. Low-density lipoprotein-cholesterol is causally associated with atherosclerosis and is the primary target for atherosclerotic CVD (ASCVD) prevention. More recently, low-grade systemic inflammation has been recognized for its role in atherosclerotic disease initiation and progression. Additionally, there is compelling evidence for combined assessments of lipid and inflammatory biomarkers to predict long-term CVD events and guide prevention efforts early in life. In the context of CVD prevention, there have also been population shifts in CVD risk factor prevalence. Obesity prevalence has increased drastically over the last three decades, contributing to disability, lower life expectancy, and higher risk of CVD through multiple mechanisms. Specifically, obesity leads to a more atherogenic lipid profile and higher levels of systemic inflammation. The purpose of this review is to synthesize available literature on the interplay between obesity, dyslipidemia, and inflammation with CVD and how optimization of these risk factors is critical for healthy aging and longevity.

PMID:
42624423
Bibliographic data and abstract were imported from PubMed on 21 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.